118P A retrospective comparison of eribulin and capecitabine in patients with HER2-negative metastatic breast cancer

Authors :: Kazuo Tamura
Tadaaki Nishikawa
Emi Noguchi
Chikako Shimizu
Yutaka Fujiwara
Natsuko Tsushita
Mayu Yunokawa
Tatsunori Shimoi
Akihiko Shimomura
Atsuko Kitano
Asuka Kawachi
Kan Yonemori
Hitomi Sumiyoshi Okuma
Makoto Kodaira
Source :: Annals of Oncology. 27
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
business.industry
HER2 negative
Hematology
medicine.disease
Metastatic breast cancer
Capecitabine
chemistry.chemical_compound
chemistry
Internal medicine
medicine
In patient
business
Eribulin
medicine.drug

Tools